NEU 2.45% $19.50 neuren pharmaceuticals limited

ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-164

  1. 850 Posts.
    lightbulb Created with Sketch. 278
    When there is money to be made it makes sense.

    This aligns with the worry I have expressed - if a lawyer finds out that Acadia has the ability to block a competitor and did not exercise the right, litigation may follow.

    I am not saying it will happen but I agree with what you said in a previous post about planning for for the worst. Ultimately, when it comes to lawyers, especially in the US, the term "ambulance chaser" has some merit, in my humble opinion.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.